NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 292 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,411,313 | +99788.7% | 40,095 | +21.8% | 0.07% | -7.9% |
| Q4 2022 | $2,414 | -99.9% | 32,912 | -19.4% | 0.08% | -24.0% |
| Q3 2022 | $3,102,000 | +3.6% | 40,830 | -5.3% | 0.10% | +11.1% |
| Q2 2022 | $2,995,000 | -16.2% | 43,098 | -0.1% | 0.09% | +5.9% |
| Q1 2022 | $3,573,000 | +2.8% | 43,125 | -6.8% | 0.08% | +21.4% |
| Q4 2021 | $3,474,000 | -20.0% | 46,264 | +23.8% | 0.07% | -22.2% |
| Q3 2021 | $4,341,000 | -56.3% | 37,366 | -16.5% | 0.09% | -49.4% |
| Q2 2021 | $9,926,000 | +3.0% | 44,747 | -38.6% | 0.18% | -0.6% |
| Q1 2021 | $9,633,000 | -26.6% | 72,880 | -3.8% | 0.18% | -28.1% |
| Q4 2020 | $13,116,000 | -6.8% | 75,797 | -40.1% | 0.25% | -33.2% |
| Q3 2020 | $14,080,000 | +25.4% | 126,496 | -33.2% | 0.37% | +16.9% |
| Q2 2020 | $11,232,000 | +10.7% | 189,404 | +25.7% | 0.32% | -12.4% |
| Q1 2020 | $10,147,000 | -19.8% | 150,689 | +0.4% | 0.36% | +13.0% |
| Q4 2019 | $12,652,000 | +11.4% | 150,135 | -1.2% | 0.32% | +4.2% |
| Q3 2019 | $11,362,000 | -11.3% | 151,942 | -25.0% | 0.31% | -2.2% |
| Q2 2019 | $12,811,000 | +17.8% | 202,617 | -10.2% | 0.32% | +16.2% |
| Q1 2019 | $10,872,000 | -15.3% | 225,705 | -41.1% | 0.27% | -24.9% |
| Q4 2018 | $12,837,000 | -46.6% | 383,421 | -16.4% | 0.36% | -36.4% |
| Q3 2018 | $24,028,000 | -11.9% | 458,559 | -47.4% | 0.57% | -16.4% |
| Q2 2018 | $27,263,000 | +35.6% | 871,029 | -5.6% | 0.68% | +38.4% |
| Q1 2018 | $20,110,000 | +15.0% | 922,468 | +6.6% | 0.49% | +19.7% |
| Q4 2017 | $17,487,000 | +40.4% | 865,671 | +38.0% | 0.41% | +37.5% |
| Q3 2017 | $12,455,000 | -14.9% | 627,476 | -25.8% | 0.30% | -18.1% |
| Q2 2017 | $14,636,000 | +45.6% | 846,036 | -30.1% | 0.36% | +42.6% |
| Q1 2017 | $10,051,000 | +13.6% | 1,210,934 | +7.4% | 0.26% | +11.3% |
| Q4 2016 | $8,851,000 | +10.8% | 1,127,486 | +20.5% | 0.23% | +10.6% |
| Q3 2016 | $7,988,000 | – | 935,308 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |